Simeon George

Insider Reports History

Entity
Individual
Location
161 Washington Street, Suite 500, Conshohocken, Pennsylvania
Signature
/s/ Sasha Keough, attorney-in-fact for Simeon George
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simeon George:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Director Common Shares 769,196 $55 M $71.50 Feb 27, 2024 Indirect
Nkarta, Inc. Director Common Stock 451,659 $4.52 M $10.00 Mar 27, 2024 Indirect
Nkarta, Inc. Director Stock Option (right to buy) 22,500 Jun 13, 2024 Direct
Design Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 19,000 Jun 13, 2024 Direct
CRISPR Therapeutics AG Director Stock Option (Right to buy) 13,000 May 30, 2024 Direct
Turning Point Therapeutics, Inc. Director Common Stock 0 $76.00 Aug 17, 2022 Indirect
Turning Point Therapeutics, Inc. Director Stock Option (right to buy) 0 Aug 17, 2022 Direct

Insider Reports Filed by Simeon George

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DSGN Design Therapeutics, Inc. Jun 13, 2024 1 0 4 Jun 17, 2024 Director, 10%+ Owner
NKTX Nkarta, Inc. Jun 13, 2024 1 0 4 Jun 14, 2024 Director
CRSP CRISPR Therapeutics AG May 30, 2024 1 0 4 May 31, 2024 Director
NKTX Nkarta, Inc. Mar 27, 2024 2 20,000,000 4 Mar 28, 2024 Director
CRSP CRISPR Therapeutics AG Feb 27, 2024 3 74,999,997 4 Feb 27, 2024 Director
CRSP CRISPR Therapeutics AG Jun 8, 2023 1 0 4 Jun 9, 2023 Director
NKTX Nkarta, Inc. Jun 7, 2023 1 0 4 Jun 9, 2023 Director
DSGN Design Therapeutics, Inc. May 31, 2023 1 0 4 Jun 2, 2023 Director, 10%+ Owner
DSGN Design Therapeutics, Inc. Dec 16, 2022 3 7,574,078 4 Dec 20, 2022 Director, 10%+ Owner
TPTX Turning Point Therapeutics, Inc. Aug 17, 2022 4 -171,278,160 4 Aug 17, 2022 Director
DSGN Design Therapeutics, Inc. Jun 15, 2022 1 0 4 Jun 16, 2022 Director, 10%+ Owner
CRSP CRISPR Therapeutics AG Jun 9, 2022 1 0 4 Jun 10, 2022 Director
NKTX Nkarta, Inc. Jun 8, 2022 1 0 4 Jun 10, 2022 Director
NKTX Nkarta, Inc. Apr 28, 2022 2 19,999,995 4 Apr 29, 2022 Director
NKTX Nkarta, Inc. Jun 13, 2021 1 0 4 Jun 15, 2021 Director
CRSP CRISPR Therapeutics AG Jun 10, 2021 1 0 4 Jun 14, 2021 Director
TPTX Turning Point Therapeutics, Inc. Jun 2, 2021 1 0 4 Jun 4, 2021 Director